SERPING1 and COVID-19: In order to perform a proof-of-concept study including diseased samples, the new immunoassays were utilized to measure C1-INH complex concentrations in a cohort of 414 COVID-19 patients (median delay between symptom onset or positive PCR test and sampling: 10.0 days (IQR 6.0 – 27.8)).